More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]

Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]

Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
Lowey Appointed Interim Lead Counsel for End-Payor Plaintiffs in Amitiza Antitrust Litigation
On June 27, 2023, Judge Richard G. Stearns of the U.S. District Court for the District of Massachusetts appointed Lowey Dannenberg, P.C. as interim lead counsel for end-payor plaintiffs in Premera Blue Cross v. Takeda Pharmaceutical Company Limited et al., No....
Blog
Admissions of Guilt in SEC Settlements
On December 17, 2021, the SEC announced a $125 million settlement with JPMorgan Chase & Co., Disposing of allegations that the bank failed to properly monitor and retain its employees’ work-related communications.[1] Pursuant to the settlement, JPMorgan admitted to the charges—the first admission...





